Permanent seed implants for breast cancer
Sunnybrook Health Sciences Centre’s new technique promises improved convenience and quality of life
Jean-Philippe Pignol, MD, PhD, FRCPC; Brian Keller, MSc; Eileen Rakovitch, MD, MSc, FRCPC and
Raxa Sankreacha, MSc

50 years of 5-fluorouracil
A review of the drug’s development, clinical usage and future prospects
Howard Lim, MD, PhD, FRCPC and Amil Shah, MDCM, FRCPC, FACP

Update from ASCO on the role of taxanes in the treatment of breast cancer
Canadian experts discuss implications of trial data
Susan Dent, MD, FRCPC and Catalin Mihalcioiu, MD, FRCPC Funded by an educational grant from Abraxis Oncology

Care navigators in oncology
An Ottawa workshop examines why we may need navigators and explores ways to improve their effectiveness
Robin Urquhart, MSc and Eva Grunfeld, MD, DPhil, FCFP

Risk stratification and febrile neutropenia
The Ottawa Hospital’s multidisciplinary protocols for inpatient and outpatient management
Gail Macartney, RN, BScH, MScA, ACNP, CONC; Rosemary Zvonar, BScPhm, ACPR; Sheryl McDiarmid, RN, BScN, MEd, MBA, ACNP, AOCN; Barbara d’Entremont Harris, RN, BScN, IBCLC and Josee Laplante, RN, BScN, CONC

The 43rd Annual Meeting of the American Society of Clinical Oncology
Review of important clinical trials with commentaries by Canadian experts
Hepatocellular cancer
Jennifer Knox, MSc, MD, FRCPC
Colorectal cancer
Hagen Kennecke, MD, MHA, FRCPC
Small cell lung cancer
Cheryl Ho, MD, FRCPC
Non small cell lung cancer
Janessa Laskin, MD, FRCPC
Non-small cell lung cancer
Nevin Murray, MD, FRCPC
Melanoma
Teresa Petrella, BSc, MD, MSc, FRCPC
Trastuzumab in breast cancer
Joseph Ragaz, MD, FRCPC

Professional meetings roster
Your calendar dates for essential conferences and symposia

New drugs and indications
A review of recent cancer therapy approvals in Canada and the U.S.